EP3826481B1 - Plant extracts and therapeutic compounds in smoking utensils and in honey complexes - Google Patents
Plant extracts and therapeutic compounds in smoking utensils and in honey complexes Download PDFInfo
- Publication number
- EP3826481B1 EP3826481B1 EP19841126.6A EP19841126A EP3826481B1 EP 3826481 B1 EP3826481 B1 EP 3826481B1 EP 19841126 A EP19841126 A EP 19841126A EP 3826481 B1 EP3826481 B1 EP 3826481B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- utensil
- utensils
- cigarette
- plant extract
- smoking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D1/00—Cigars; Cigarettes
- A24D1/002—Cigars; Cigarettes with additives, e.g. for flavouring
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F25/00—Devices used by the smoker for controlling the moisture content of, or for scenting, cigars, cigarettes or tobacco
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K47/00—Beehives
- A01K47/06—Other details of beehives, e.g. ventilating devices, entrances to hives, guards, partitions or bee escapes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
- A24B15/282—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by indirect addition of the chemical substances, e.g. in the wrapper, in the case
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
- A24B15/283—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
- A24B15/284—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances the additive being bound to a host by chemical, electrical or like forces, e.g. use of precursors, inclusion complexes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/302—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by natural substances obtained from animals or plants
- A24B15/303—Plant extracts other than tobacco
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D1/00—Cigars; Cigarettes
- A24D1/18—Selection of materials, other than tobacco, suitable for smoking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
Definitions
- the present invention relates to the field of processing plant extracts and/or therapeutic compounds, and more particularly, to using plant extracts and/or therapeutic compounds in smoking utensils and in honey complexes.
- Plant extracts and therapeutic compounds are being used in a range of methods, some of which being disadvantageous with respect to the form, efficiency and predictability of the administered compounds.
- Document WO2017/103795A1 discloses a method for incorporating a flavor material into combination with a tobacco product.
- One aspect of the present invention provides a method of administering a plant extract at a controlled amount, the method comprising: applying the plant extract to a utensil that is designed to be inserted into a smoking appliance, indicating at least one compound that is included in the plant extract on the utensil, and using the smoking appliance to inhale the plant extract from the utensil inserted there within.
- the present application discloses a method of administering at least one therapeutic compound at a controlled amount, the method comprising: applying the at least one therapeutic compound to a utensil that is designed to be inserted into a smoking appliance, and using the smoking appliance to inhale the at least one therapeutic compound from the utensil inserted therewithin.
- One aspect of the present invention provides a utensil comprising plant extract(s) and/or therapeutic compound(s) and optionally indication(s) of the extract(s), compounds thereof and/or therapeutic compound(s) in the utensil, wherein the utensil is designed to be inserted into a smoking appliance and release the plant extract(s) and/or therapeutic compound(s) upon smoking the smoking appliance.
- the present application discloses a method comprising deriving a complex of honey and a plant extract by applying the plant extract onto a substrate and attaching the substrate onto at least one hive region that is stepped on by bees, wherein the applying and the substrate are configured to soil bees that step on the substrate by the plant extract, and wherein the complex is collected from the hive.
- the present application discloses a substrate infused with a plant extract that is attachable onto at least one hive region that is stepped on by bees, wherein the substrate is configured to soil bees that step thereon by the plant extract.
- Embodiments of the present invention provide efficient and economical methods and mechanisms for using plant extracts and/or therapeutic compounds, and thereby provide improvements to the technological field of administering plant extracts and/or therapeutic compounds, with an emphasize on cannabis extracts and oils and related compounds.
- Methods and utensils are provided for administering plant extract(s) and/or therapeutic compound(s) at controlled amounts via smoking, as well as for providing complexes of honey and plant extracts and/or therapeutic compound(s).
- Plant extract(s) and/or therapeutic compound(s) may be used in utensils that are inserted into a smoking appliance, and have indications of the compounds and/or characteristics of the plant extract(s) and/or therapeutic compound(s). Upon smoking, using the smoking appliance, the plant extract(s) and/or therapeutic compound(s) may be inhaled in pre -defined amounts.
- complexes of honey and plant extract(s) and/or therapeutic compound(s) may be provided by letting bees step on or be soiled by plant extract(s) and/or therapeutic compound(s) on their way into the beehive, causing them to incorporate the plant extract(s) and/or therapeutic compound(s) into the honey preparation process.
- Resulting complexes may be a preferable and particularly beneficial way of administering plant extract(s) and/or therapeutic compound(s), e.g., cannabis extracts.
- plant extract is used in a broad sense, as any substance or compositions of substances that are removed from plant tissues, namely extracted therefrom, by various technical means.
- Plant extracts may include extracts from multiple plant species, and may include multiple extract from the same plant species which are achieved using different methods, or combinations thereof.
- Plant extracts may also be augmented or enriched with synthetic compounds, either ones that are present in the plant extract or additives.
- plant extracts may comprise therapeutic compounds of various sources.
- Figures 1-3 are schematic illustrations of systems 100, utensils 110 and packaged sets 130 thereof, according to some embodiments of the invention.
- Utensils 110 may comprise plant extract(s) comprising at least one compound, and an indication 120 of the at least one compound; utensils 110 being designed to be inserted into a smoking appliance 90 and release the plant extract(s) upon smoking of smoking appliance 90.
- smoking appliance 90 may comprise cigarette and utensil 110 may comprise a stick that is thinner than cigarette 90 and has a sharp end configured to be inserted (e.g., sticked, impaled, pushed) into tobacco of cigarette 90 throughout most of a length of cigarette 90.
- Systems 100 for delivery of plant extracts comprise smoking appliance 90 with inserted utensil(s) 110.
- utensils 110 may be burned to release the plant extract, or may remain at least partly intact upon releasing the plant extract.
- the rate of burning and/or releasing of the plant extract may be determined by the structure and composition of utensils 110 with respect to typical burning profiles of smoking appliance 90 - providing a specified profile of released compound concentrations and/or amounts.
- the burning rate, or compound release rate may be similar to the burning rate of the tobacco blend, possibly in relation to bum rates of different blends and/or different types of smoking appliance 90.
- utensils 110 may be made of porous material. The porous material may provide a burning rate of utensil 110 that depends on the rate of air flow therethrough, possibly similar to the variable burning rate of a smoked cigarette, which depends on the intensity of air flow therethrough.
- utensils 110 may comprise therapeutic compound(s), possibly at different amounts or combinations. Utensils 110 may be designed to be inserted into smoking appliance 90 and release the therapeutic compound(s) upon smoking of smoking appliance 90.
- smoking appliance 90 may comprise cigarette and utensil 110 may comprise a stick that is thinner than cigarette 90 and has a sharp end configured to be inserted into tobacco of cigarette 90 throughout most of a length of cigarette 90.
- Systems 100 for delivery of therapeutic compound(s) comprise smoking appliance 90 with inserted utensil(s) 110.
- the therapeutic compound(s) may comprise synthetic compounds that are similar to compounds found in plant extracts, and therapeutic compound(s) may be added to plant extract(s) in utensil 110.
- synthetic cannabinoids may be added to utensil 110 with cannabis oil as the plant extract.
- utensils 110 may be configured to bum and/or release the plant extract at approximately the same rate as the tobacco burn rate of smoking appliance 90 into which it is to be inserted.
- the combustion rate and/or plant extract release rate of utensil 110 may be determined according to the materials from which it is prepared, coatings with which it is coated and the like, as well as a level of porosity of utensil 110 or components of specified mixes of burning materials of which utensil 110 is made, that may be adjusted to determine the burning rate of utensil 110. Accordingly, different grades of utensils 110 may be prepared, each of which may have a different combustion rate.
- Indication(s) 120 may provide information concerning the composition and/or amount of plant extract(s) and/or compound(s) thereof in a way that is standardized.
- indication(s) 120 may be configured to provide an inhaled amount of the compounds when using utensil 110 with smoking appliance 90 (e.g., in terms of amounts of THC per cigarette).
- utensil 110 usable in one smoking appliance 90 may include a pre-defined amount and/or composition of plant extract which is released during the smoking of one smoking appliance 90 with utensil 110 used therein.
- Indications 120 thus provide a highly controllable way of consuming plant extract(s) and/or compound(s) while smoking.
- indications 120 illustrated schematically in Figures 1 and 2 may comprise color coded regions along stick-like utensil 110.
- Utensils 110 may be shaped in various ways that allow their insertion into smoking appliance 90 and provide effective release of the plant extract, possibly to provide the smoker with specified amounts of the at least one compound.
- Utensils 110 may be stick-like and be configured to be insertable into any smoking appliance 90, e.g., a cigarette, a cigar or any other smoking article.
- Utensils 110 may be made of any material which is safe to be smoked with into smoking appliance 90, insertable thereto, and able to receive, absorb and upon smoking release the plant extract and/or compounds thereof.
- Utensils 110 may be sufficiently rigid to be inserted into a conventional cigarette and at the same time, not be brittle to prevent its breaking when inserted into the conventional cigarette, a cigar or any other smoking article.
- smoking appliance 90 may comprise various herbs other than tobacco, or possibly any other medium that may be configured to mechanically accept utensils 110 and be smoked therewith.
- smoking appliance 90 may be configured as an artificial delivery device for plant extract(s) and/or therapeutic compounds, having a medium (e.g., a particulate or porous medium) that receives utensil(s) 110 mechanically, and may be activated by burning to release the plant extract(s) and/or therapeutic compounds from utensil(s) 110, to be inhaled by the user.
- a medium e.g., a particulate or porous medium
- the medium, and possibly utensil(s) 110 may be configured to burn and/or release the respective the plant extract(s) and/or therapeutic compounds at specified temperatures and under specified conditions that are different from typical tobacco burning conditions, e.g., to enhance the efficiency of delivery of the plant extract(s) and/or therapeutic compounds to the user.
- utensils 110 may be between about 1-15 cm long, wherein the length may depend on the length of smoking appliance 90 into which it is to be inserted.
- utensils 110 may be prepared at any length and then be trimmable (e.g., by the user, possibly at a blunt end or possibly at a sharp edge thereof) according to the length of smoking appliance 90 before or after insertion thereinto.
- utensils 110 may be between about 0.5-3mm wide, such that is may be easily inserted into a conventional cigarette, avoiding harm or distortion of smoking appliance 90 and allowing regular use thereof.
- the stick-like device has a point, in order to enable the easy insertion thereof into the cigarette.
- the stick-like device may be shaped similarly to a toothpick, which may or may not be blunt on one side, as long as it is sharp on the other side to ease insertion into the cigarette.
- the stick-like device may be trimmed before insertion into the cigarette, it may be trimmed at an angle, so as to form a pointed end for insertion.
- utensils 110 may be made of any appropriate material that provide the required mechanical characteristics and allow incorporation of the plant extract.
- utensils 110 may be made of wood, paper (e.g., hardened paper) or plastics such as polymers, e.g., polysaccharides, with cross-linked plant extract(s).
- the plant extract(s) may be associated to utensils 110 by various methods, such as immersion, soaking, coating, cross-linking, etc.
- utensils 110 may be prepared by adding a cannabis oil into a polysaccharide solution; pouring the solution into a mold comprising at least one compartment, the compartment has the size and shape of utensils 110; and chemically hardening or physically curing the solution in the compartment in order to obtain utensils 110.
- the mold may comprise two or more compartments, with possibly different compartments differing from each other in shape, size or both.
- Utensils 110 may further be coated and/or inserted into respective sleeve elements, and aromatic materials, colors, hardening materials and/or curing material(s) may be added to the solution.
- Hardening methods may include chemical hardening by cross-linking and/or physical hardening by UV (ultraviolet) and/or heat radiation curing. Indications 120 may then be applied (e.g., attached or printed) upon utensils 110.
- utensils 110 may have inner spaces or compartments (with or without openings) into which the plant extract may be introduced, e.g., by immersion or injection.
- utensils 110 may be made of metal, e.g., having internal compartments or grooves configured to receive and hold the plant extract(s) and release the plant extract(s) upon heating of metal utensil 110 during smoking.
- metal utensils 110 may even be re-usable, e.g., by cleaning them after use and dipping them in plant extracts, as the spaces or grooves therein may be configured to hold a pre-defined amount of plant extract.
- utensils 110 may have a hollow channel through their whole length or through part of their length, e.g., like a borehole, which may receive and/or be filled by the plant extract.
- utensils 110 may comprise the plant extract(s) or the user may introduce selected plant extract(s) into utensil 110, e.g., with utensil 110 configured to receive a pre defined amount of plant extract.
- utensil 110 may be provided with the plant extract(s) (e.g., cannabis oil, see below) and may be prepared by the user for smoking, e.g., by soaking or dipping utensil 110 in the plant extract and/or by filling hollow groove(s) or compartment(s) therein.
- Certain embodiments comprise kits for preparation of utensil 110 by the user (either first-time or in a reusable version of utensil 110), with utensil(s) 110, plant extract(s) and respective instructions.
- kits may comprise cannabis-free utensils 110, cannabis oil, instructions for incorporating the cannabis oil into the cannabis-free utensils 110; and optionally means for incorporating the cannabis oil into the cannabis-free utensils 110 (e.g., an appropriately- shaped container, wetting means, etc.) ⁇
- kits may comprise different kinds of utensils 110, containing different type of plant extract(s) and/or therapeutic compound(s).
- users may select different types or compositions of plant extract(s) and/or therapeutic compound(s) at different times (e.g., during the day and at the evening), and therefore may use corresponding utensils 110 with different indicated compounds or combinations or amounts of compounds (e.g., having different amounts of THC and CBD).
- utensils 110 may be clad (covered or coated) by any appropriate sleeve-like element (not shown) configured to provide the desired physical properties, such as desired shape, strength, rigidity, and the like and/or configured to hold and then release pre defined amounts of plant extract(s).
- the sleeve or sleeve -like element may be removable or non removable from utensil 110.
- utensils 110 may be made of soft material such as dough that is prepared to have specified shape, strength and resilience that are required for insertion thereof into smoking appliance 90, and into which the plant extract may be incorporated.
- utensils 110 may be configured to be very thin, flexible or flakey - to be used in hand- rolled cigarettes or in pipes. The amount of used utensil 110 may be related to the amount of released plant extract by diverse indications.
- the plant extract may comprise a cannabis extract and/or oil.
- Indications 120 may comprise indication(s) 121 for a THC (tetrahydrocannabinol) content or level, and/or indications(s) 122 for predominant component(s) of the cannabis extract and/or oil, such as other cannabinoids, terpenes, or aromas (see non-limiting example in Figure 2 ).
- Other possible plant extract(s), usable in utensils 110 and/or as additions to the cannabis extract comprise any plant extract or oil, various terpenes or any other plant extract or releasable compound.
- any of menthol, pine oil, clove oil, eucalyptus oil, orange oil, lemon oil, or other essential oils, as well as flavor essences (e.g., lemon flavor, bubble gum flavor, enhanced cannabis flavors) may be included in utensil 110.
- utensils 110 may comprise condensed cannabis oil in a matrix configured to endow the product with the right rigidity, e.g., make it tooth -pick-like, so that it can be easily inserted to any existing cigarette, burns at the same rate as the cigarette, and leave no particles and minimum ash, while providing the cannabis oil or its products to the user.
- Utensils 110 may be provided at a range of different concentrations of CBD, THC, CBG (cannabigerol), and with different aromas (e.g., mint, lemon, orange) - which are indicated, e.g., by color code(s) on each utensil 110
- Certain embodiments comprise packaged set(s) 130 including a plurality of utensils 110 which may differ with respect to the at least one compound and the corresponding indications 120, as exemplified schematically in Figure 3 .
- Complementary compositions of the plant extracts may be provided in each set (e.g., ones with little THC and much CBD and ones with much CBD and little THC).
- utensils 110 may be configured to allow insertion of more than one utensil 110 at a time into smoking appliance 90, e.g., utensils may be configured as thin spikes that can be inserted into cigars, or as rollable threads with color indications, and the user may select a few utensils 110 having a required combination of the plant extracts for each use (smoking) of smoking appliance 90.
- such thin utensils 110 may comprise means for interconnecting multiple utensils 110 to make their insertion into smoking appliance 90, e.g., grooves or nooks may be used to attach utensils 110 to each other and enhance their longitudinal structural stability upon insertion.
- packaged set 130 of utensils 110 may have cannabis extracts and/or oils having different levels of THC and/or different levels of other cannabinoids and/or of other components (e.g., terpenes) or characteristics (e.g., aromas) with corresponding indications 120, as illustrated schematically in Figure 3 .
- cannabis extracts and/or oils having different levels of THC and/or different levels of other cannabinoids and/or of other components (e.g., terpenes) or characteristics (e.g., aromas) with corresponding indications 120, as illustrated schematically in Figure 3 .
- the contents of the cannabis oil incorporated into utensils 110, and the ratios between the active ingredients found therein, may be determined according to any known protocols. Therefore, many types of utensils 110 may be prepared, each having a specific, predefined content and ratio of active ingredients, in particular CBD (cannabidiol) and THC.
- the various types of utensils 110 may be labeled according to their content, e.g., by size, color code, shape, labels and the like as indications 120.
- the ratio between CBD and THC may be 10:1
- utensils 110 may weigh about 100-150 mg and may correspondingly contain about 20-60mg of CBD, 2-6mg of THC, as well as additional supporting and hardening materials.
- utensils 110 may comprise any of about 20, 25, 30, 35, 40, 45, 50, 55 or 60 mg of CBD. According to some embodiments, utensils 110 may comprise any of about 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5 or 6.0mg THC.
- the cross linking may be performed using various cross-linking methods and materials.
- the cross-linking may be performed using microbial poly (gamma-glutamic acid) (PGA) with polysaccharides and the cannabis oil, which may be cross-liked as well or incorporated into the cross-linked product of the PGA and the polysaccharide.
- PGA microbial poly (gamma-glutamic acid)
- the cross linking may be performed by using polylactic acid (PLA), including poly(L)lactide (PLLA) and poly(D)lactide (PLDA).
- PLA polylactic acid
- PLA poly(L)lactide
- PLDA poly(D)lactide
- the cross linking may be performed using any appropriate cross-linkable composite, for example a composite prepared from polyethylene glycol) dimethyl ether (PEGDE)-500, LiCl04, fumed silica and about 10%wt methyl, butyl or octyl methacrylate.
- the cross linking may be performed using any appropriate polysaccharide.
- the cross linking may be performed by pre-chemically treating the cannabis oil using thiol-ene addition reactions, azide-alkyne cyclo addition reactions, Diels- Alder reactions and the like, wherein the formed adduct oil products are then cross-linked.
- the cannabis oil may also be pre-treated using triazolinediones (TADs), such as 4- phenyl-1,2,4-triazoline-3,5-dione and subsequently cross-linked.
- TADs triazolinediones
- the cross-linking mechanism may be selected to avoid releasing toxic fumes when utensil 110 in smoking appliance 90 is smoked.
- the material from which utensil 110 is prepared may be non-toxic and combustible, thereby providing a utensil that may burn together with the cigarette, while releasing carbonized plant extracts (e.g., cannabis oil), without having an intoxication effect on the user.
- the combustion rate of the stick-like device may be similar to that of a conventional cigarette.
- utensils 110 may further comprise additives such as coloring and flavoring products, as well as enhancers, such as cocoa solids, licorice, tobacco extracts, and various sugars, and possibly perfume -like flavor(s)/fragrance(s) - any of which may be incorporated in utensils 110 as additional plant extracts and/or as additives.
- utensils 110 may be coated by a material that contains aromatic elements, possibly one or more plant extracts.
- disclosed systems 100 and utensils 110 provide well-measured amounts of plant extracts that can be easily specified and controlled. Particularly in case of cannabis oils, disclosed systems 100, utensils 110 and methods 150 disclosed below - provide a reliable way of consuming cannabis oils and components thereof in a highly controllable and standardized methods. Indications 120 are further configured to clearly indicate the compounds to be smoked, and allow the user to select the required composition for any smoke.
- disclosed systems 100 and utensils 110 provide active materials at pre defined and known dosage, which is required e.g., in regulation procedures for medical use of cannabis and/or other plant extracts and/or any therapeutic compound.
- the amount of any of the active materials e.g., cannabinoids
- therapeutic compounds that target the brain pass the blood brain barrier with higher efficiency when inhaled, and may be administered using systems 100 and utensils 110.
- utensil 110 and/or therapeutic compounds therewithin may be configured to further enhance the bioavailability of the latter by the heating and/or carbonization thereof during the administration process.
- disclosed systems 100 and utensils 110 may be used with the therapeutic compound(s) to provide new ways of administering dmgs that can be inhaled and are not damaged (or possibly modified favorably) by the smoking procedure.
- Additional advantages include simple handling of utensils 110 (do not require rolling), simpler regulation compared to cannabis inflorescences due to the known and controlled amounts of THC or any other cannabinoid (e.g., CBD, CBN (Cannabinol), CBG, etc.) or any other compound (e.g., terpenes) in case of using cannabis extract or oil, consistent and repeatable smoking experience, and brand building possibilities due to the repeatability of the experience.
- cannabinoid e.g., CBD, CBN (Cannabinol), CBG, etc.
- any other compound e.g., terpenes
- utensils 110 may be used to deliver various plant extracts and possibly even therapeutic drugs or compounds that can be inhaled after heating and/or carbonizing during smoking.
- Figure 4 is a high-level flowchart illustrating a method 150 of administering a plant extract or any compound at a controlled amount, according to some embodiments of the invention.
- the method stages may be carried out with respect to systems 100 and utensils 110 described above, which may optionally be configured to implement method 150.
- Method 150 may comprise the following stages, irrespective of their order.
- Method 150 may comprise administering plant extract(s) at a controlled amount (stage 152) by applying the plant extract(s) to utensil(s) designed to be inserted into a smoking appliance (stage 155), indicating at least one compound that is included in the plant extract(s) on the utensil(s) (stage 160), and using the smoking appliance to inhale the plant extract(s) from the utensil(s) inserted therewithin (stage 170).
- method 150 may comprise administering at least one therapeutic compound at a controlled amount (stage 153) by applying the at least one therapeutic compound to utensil(s) designed to be inserted into a smoking appliance (stage 155) and using the smoking appliance to inhale the therapeutic compound(s) from the utensil(s) inserted therewithin (stage 170).
- method 150 may further comprise designing the utensil(s) to be inserted into the smoking appliance (stage 157), e.g., by sticking or pushing the utensil into the smoking appliance.
- the smoking appliance may be a cigarette and the utensil may be made as a stick that is thinner than the cigarette and has a sharp end configured to be inserted into tobacco of the cigarette throughout at least some, or possibly most, of a length of the cigarette (stage 158).
- Corresponding embodiments may be applicable to cigars or other smoking appliances such as pipes, hand-rolled cigarettes, bongs etc.
- method 150 may further comprise providing a plurality of utensils with different levels of the indicated at least one compound and/or with different combinations of the therapeutic compound(s) (stage 180).
- the plant extract(s) may comprise cannabis extract(s) and/or oil(s), and/or essential plant oils.
- Method 150 may further comprise indicating a THC level, predominant components (e.g., cannabinoids, terpenes) and/or characteristics (e.g., aromas) of the cannabis extract and/or oil (stage 182).
- Method 150 may further comprise providing a plurality of utensils with different levels of THC and/or with different predominant components and/or characteristics (stage 185).
- FIGS 5 and 6 are schematic illustrations of systems 200 having beehives 80 configured to provide complexes of honey and plant extracts and/or therapeutic compound(s), according to some embodiments of the invention.
- Systems 200 may comprise beehives 80 having substrate(s) 210 infused with plant extract(s) and/or therapeutic compound(s) - that are attachable onto at least one hive region 85 that is stepped on by bees, wherein substrate(s) 210 are configured to soil bees that step thereon with the plant extract and/or the therapeutic compound(s).
- substrate(s) 210 such as pads (made e.g., of sponge or foam) soaked by the plant extract(s) and/or the therapeutic compound(s), may be attached to entrance(s) to hive 80 and may have any corresponding shape (see, e.g., in Figures 5 and 6 , the openings and corresponding substrates 210 may be straight or round, narrow or broad, etc.).
- bees stepping on substrate 210 and being soiled by the plant extract(s) and/or the therapeutic compound(s) may then mix the plant extracts, intentionally or unintentionally, in the produced honey to yield a complex of honey and the plant extracts and/or therapeutic compound(s), which is not achievable by other means (such as mixing prepared honey with plant extracts and/or therapeutic compounds).
- the plant extracts may comprise cannabis extract and/or oil, to yield a complex of honey and cannabis that is not achievable by other means, as the complexes may include bonds between the honey and the plant extracts that are formed during the honey processing by the bees.
- the cannabis in the cannabis-honey complex may be incorporated into the honey during the honey's preparation process by the bees from pollen.
- the cannabis-honey complex may have a unique HPLC (High Pressure/Performance Liquid Chromatography) pattern, different from other types of honey and/or other types of cannabis.
- the HPLC fingerprint of the cannabis-honey complex is unique in comparison to other types of honey and/or other types of cannabis.
- beehive 80 may be designed to cause at least one part of the body of the bees entering beehive 80 to touch at least part of substrate 210 at entrance 85.
- regions 85 may be configured to cause bees contact substrate 210 with cannabis oil with their bodies, e.g., legs, abdomen and/or thorax, while entering beehive 80.
- the thus soiled bees may be at least partly coated or stained with cannabis oil, which they may then take with them into beehive 80 and possibly mix with honey to yield the cannabis-honey complex during the honey-preparation process.
- beehive 80 may be designed to induce contact of entering bees with substrate 210.
- the diameter or width of the entrance 85 to beehive 80 may be restricted, so that at least on one of its dimensions is between about 0.3-1.0cm and thereby induce contact between the bee and substrate 210.
- smoke of carbonized cannabis oil may be distributed onto and/or in the surroundings of beehive 80, exposing the bees and/or beehive 80 to carbonized cannabis, which may then be incorporated into the honey to yield the cannabis-honey complex.
- cannabis oil may be sprayed onto the internal elements of beehive 80, enhancing the incorporation of the cannabis oil by the bees into the cannabis-honey complex.
- disclosed cannabis-honey complexes and/or complexes of honey and therapeutic compound(s) - may have enhanced therapeutic effects, with respect to either honey alone, cannabis alone, and therapeutic compound(s) alone, or mechanical mixtures thereof.
- the preparation process of the cannabis-honey complex by the bees may induce additional beneficial properties to the disclosed products. Examples for such properties include therapeutic and/or recreational effects.
- cannabis-honey complexes may be more effective and/or more becoming than other methods of cannabis administration.
- Certain embodiments comprise processes of preparing new complexes of honey and therapeutic compound(s) through the disclosed methods and systems of soiling bees with the therapeutic compound(s) and letting the bees integrate the therapeutic compound(s) into the honey.
- Figure 7 is a high-level flowchart illustrating a method 250, not covered by the claimed subject-matter, of deriving a complex of honey and plant extract(s) and/or therapeutic compound(s), according to some embodiments of the invention.
- the method stages may be carried out with respect to systems 200 described above, which may optionally be configured to implement method 250.
- Method 250 may comprise the following stages, irrespective of their order.
- Method 250 comprises deriving a complex of honey and one or more plant extract and/or therapeutic compound(s) (stage 255) by applying the plant extract and/or therapeutic compound(s) onto a substrate (stage 260) and attaching the substrate onto at least one hive region that is stepped on by bees (stage 265). Applying 260 and the substrate are configured to soil bees that step on the substrate with the plant extract and/or therapeutic compound(s) (stage 270), method 250 further comprises collecting the complex from the hive (stage 280). Method 250 may further comprise configuring the substrate as one or more pads attached to at least one entrance to the hive (stage 267). The pads may be shaped according to the corresponding shape of the openings in the hives, e.g., straight or round, narrow or broad, etc.
- the plant extract may comprise cannabis extract and/or oil
- disclosed method 250 may provide an efficient way of complexing cannabis extract and/or components thereof with honey.
- systems 200 and/or methods 250 may be configured to produce complexes of honey and therapeutic compound(s) that may be used as new therapeutic compounds having new therapeutic effects.
- an embodiment is an example or implementation of the invention.
- the various appearances of "one embodiment”, “an embodiment”, “certain embodiments” or “some embodiments” do not necessarily all refer to the same embodiments.
- various features of the invention may be described in the context of a single embodiment, the features may also be provided separately or in any suitable combination.
- the invention may also be implemented in a single embodiment.
- Certain embodiments of the invention may include features from different embodiments disclosed above, and certain embodiments may incorporate elements from other embodiments disclosed above.
- the disclosure of elements of the invention in the context of a specific embodiment is not to be taken as limiting their use in the specific embodiment alone.
- the invention can be carried out or practiced in various ways and that the invention can be implemented in certain embodiments other than the ones outlined in the description above.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Environmental Sciences (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
- The present invention relates to the field of processing plant extracts and/or therapeutic compounds, and more particularly, to using plant extracts and/or therapeutic compounds in smoking utensils and in honey complexes.
- Plant extracts and therapeutic compounds are being used in a range of methods, some of which being disadvantageous with respect to the form, efficiency and predictability of the administered compounds.
- Document
US2008/0029106A1 discloses an immobilized additive inserts in smoking articles. - Document
US2072361A discloses a device for flavoring cigarettes. - Document
US2017/347701A1 discloses a method for administering tetra-hydrocannabinol in tobacco filled in a cigarette. - Document
WO2017/103795A1 discloses a method for incorporating a flavor material into combination with a tobacco product. - The following is a simplified summary providing an initial understanding of the invention. The summary does not necessarily identify key elements nor limit the scope of the invention, but merely serves as an introduction to the following description.
- One aspect of the present invention provides a method of administering a plant extract at a controlled amount, the method comprising: applying the plant extract to a utensil that is designed to be inserted into a smoking appliance, indicating at least one compound that is included in the plant extract on the utensil, and using the smoking appliance to inhale the plant extract from the utensil inserted there within.
- In an embodiment not covered by the claimed subject-matter, the present application discloses a method of administering at least one therapeutic compound at a controlled amount, the method comprising: applying the at least one therapeutic compound to a utensil that is designed to be inserted into a smoking appliance, and using the smoking appliance to inhale the at least one therapeutic compound from the utensil inserted therewithin.
- One aspect of the present invention provides a utensil comprising plant extract(s) and/or therapeutic compound(s) and optionally indication(s) of the extract(s), compounds thereof and/or therapeutic compound(s) in the utensil, wherein the utensil is designed to be inserted into a smoking appliance and release the plant extract(s) and/or therapeutic compound(s) upon smoking the smoking appliance.
- In an embodiment not covered by the claimed subject-matter, the present application discloses a method comprising deriving a complex of honey and a plant extract by applying the plant extract onto a substrate and attaching the substrate onto at least one hive region that is stepped on by bees, wherein the applying and the substrate are configured to soil bees that step on the substrate by the plant extract, and wherein the complex is collected from the hive.
- In an embodiment not covered by the claimed subject-matter, the present application discloses a substrate infused with a plant extract that is attachable onto at least one hive region that is stepped on by bees, wherein the substrate is configured to soil bees that step thereon by the plant extract.
- These, additional, and/or other aspects and/or advantages of the present invention are set forth in the detailed description which follows; possibly inferable from the detailed description; and/or leamable by practice of the present invention.
- For a better understanding of embodiments of the invention and to show how the same may be carried into effect, reference will now be made, purely by way of example, to the accompanying drawings in which like numerals designate corresponding elements or sections throughout.
- In the accompanying drawings:
-
Figures 1-3 are schematic illustrations of systems, utensils and packaged sets thereof, according to some embodiments of the invention. -
Figure 4 is a high-level flowchart illustrating a method of administering a plant extract or any compound at a controlled amount, according to some embodiments of the invention. -
Figures 5 and 6 are schematic illustrations of systems having beehives configured to provide complexes of honey and plant extracts, according to some embodiments not covered by the claimed subject-matter of the invention. -
Figure 7 is a high-level flowchart illustrating a method of deriving a complex of honey and plant extract(s) and/or therapeutic compound(s), according to some embodiments not covered by the claimed subject-matter of the invention. - In the following description, various aspects, either covered or not covered by the claimed subject-matter of the present invention, are described. For purposes of explanation, specific configurations and details are set forth in order to provide a thorough understanding of the present invention. However, it will also be apparent to one skilled in the art that the present invention may be practiced without the specific details presented herein. Furthermore, well known features may have been omitted or simplified in order not to obscure the present invention. With specific reference to the drawings, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of the present invention only, and are presented in the cause of providing what is believed to be the most useful and readily understood description of the principles and conceptual aspects of the invention. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for a fundamental understanding of the invention, the description taken with the drawings making apparent to those skilled in the art how the several forms of the invention may be embodied in practice.
- Before at least one embodiment of the invention is explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is applicable to other embodiments that may be practiced or carried out in various ways as well as to combinations of the disclosed embodiments. Also, it is to be understood that the phraseology and terminology employed herein are for the purpose of description and should not be regarded as limiting.
- Embodiments of the present invention provide efficient and economical methods and mechanisms for using plant extracts and/or therapeutic compounds, and thereby provide improvements to the technological field of administering plant extracts and/or therapeutic compounds, with an emphasize on cannabis extracts and oils and related compounds. Methods and utensils are provided for administering plant extract(s) and/or therapeutic compound(s) at controlled amounts via smoking, as well as for providing complexes of honey and plant extracts and/or therapeutic compound(s). Plant extract(s) and/or therapeutic compound(s) may be used in utensils that are inserted into a smoking appliance, and have indications of the compounds and/or characteristics of the plant extract(s) and/or therapeutic compound(s). Upon smoking, using the smoking appliance, the plant extract(s) and/or therapeutic compound(s) may be inhaled in pre -defined amounts.
- Using plant extract(s) and/or therapeutic compound(s) in such way enables standardization of amounts and components thereof, and may be particularly applicable to cannabis oils. Furthermore, complexes of honey and plant extract(s) and/or therapeutic compound(s) may be provided by letting bees step on or be soiled by plant extract(s) and/or therapeutic compound(s) on their way into the beehive, causing them to incorporate the plant extract(s) and/or therapeutic compound(s) into the honey preparation process. Resulting complexes may be a preferable and particularly beneficial way of administering plant extract(s) and/or therapeutic compound(s), e.g., cannabis extracts. It is noted that the term "plant extract" is used in a broad sense, as any substance or compositions of substances that are removed from plant tissues, namely extracted therefrom, by various technical means. Plant extracts, as used herein, may include extracts from multiple plant species, and may include multiple extract from the same plant species which are achieved using different methods, or combinations thereof. Plant extracts may also be augmented or enriched with synthetic compounds, either ones that are present in the plant extract or additives. In particular, plant extracts may comprise therapeutic compounds of various sources.
-
Figures 1-3 are schematic illustrations ofsystems 100,utensils 110 and packagedsets 130 thereof, according to some embodiments of the invention. -
Utensils 110 may comprise plant extract(s) comprising at least one compound, and anindication 120 of the at least one compound;utensils 110 being designed to be inserted into asmoking appliance 90 and release the plant extract(s) upon smoking ofsmoking appliance 90. For example,smoking appliance 90 may comprise cigarette andutensil 110 may comprise a stick that is thinner thancigarette 90 and has a sharp end configured to be inserted (e.g., sticked, impaled, pushed) into tobacco ofcigarette 90 throughout most of a length ofcigarette 90.Systems 100 for delivery of plant extracts comprisesmoking appliance 90 with inserted utensil(s) 110. - Upon use,
utensils 110 may be burned to release the plant extract, or may remain at least partly intact upon releasing the plant extract. The rate of burning and/or releasing of the plant extract may be determined by the structure and composition ofutensils 110 with respect to typical burning profiles of smoking appliance 90 - providing a specified profile of released compound concentrations and/or amounts. For example, the burning rate, or compound release rate may be similar to the burning rate of the tobacco blend, possibly in relation to bum rates of different blends and/or different types ofsmoking appliance 90. In certain embodiments,utensils 110 may be made of porous material. The porous material may provide a burning rate ofutensil 110 that depends on the rate of air flow therethrough, possibly similar to the variable burning rate of a smoked cigarette, which depends on the intensity of air flow therethrough. - In certain embodiments not covered by the claimed subject-matter,
utensils 110 may comprise therapeutic compound(s), possibly at different amounts or combinations.Utensils 110 may be designed to be inserted intosmoking appliance 90 and release the therapeutic compound(s) upon smoking ofsmoking appliance 90. For example,smoking appliance 90 may comprise cigarette andutensil 110 may comprise a stick that is thinner thancigarette 90 and has a sharp end configured to be inserted into tobacco ofcigarette 90 throughout most of a length ofcigarette 90.Systems 100 for delivery of therapeutic compound(s) comprisesmoking appliance 90 with inserted utensil(s) 110. - In certain embodiments not covered by the claimed subject-matter, the therapeutic compound(s) may comprise synthetic compounds that are similar to compounds found in plant extracts, and therapeutic compound(s) may be added to plant extract(s) in
utensil 110. For example, synthetic cannabinoids may be added toutensil 110 with cannabis oil as the plant extract. - According to some embodiments,
utensils 110 may be configured to bum and/or release the plant extract at approximately the same rate as the tobacco burn rate ofsmoking appliance 90 into which it is to be inserted. According to some embodiments, the combustion rate and/or plant extract release rate ofutensil 110 may be determined according to the materials from which it is prepared, coatings with which it is coated and the like, as well as a level of porosity ofutensil 110 or components of specified mixes of burning materials of whichutensil 110 is made, that may be adjusted to determine the burning rate ofutensil 110. Accordingly, different grades ofutensils 110 may be prepared, each of which may have a different combustion rate. - Indication(s) 120 may provide information concerning the composition and/or amount of plant extract(s) and/or compound(s) thereof in a way that is standardized. For example, indication(s) 120 may be configured to provide an inhaled amount of the compounds when using
utensil 110 with smoking appliance 90 (e.g., in terms of amounts of THC per cigarette). - For example,
utensil 110 usable in onesmoking appliance 90, may include a pre-defined amount and/or composition of plant extract which is released during the smoking of onesmoking appliance 90 withutensil 110 used therein.Indications 120 thus provide a highly controllable way of consuming plant extract(s) and/or compound(s) while smoking. For example,indications 120 illustrated schematically inFigures 1 and 2 may comprise color coded regions along stick-like utensil 110. -
Utensils 110 may be shaped in various ways that allow their insertion intosmoking appliance 90 and provide effective release of the plant extract, possibly to provide the smoker with specified amounts of the at least one compound.Utensils 110 may be stick-like and be configured to be insertable into anysmoking appliance 90, e.g., a cigarette, a cigar or any other smoking article.Utensils 110 may be made of any material which is safe to be smoked with intosmoking appliance 90, insertable thereto, and able to receive, absorb and upon smoking release the plant extract and/or compounds thereof.Utensils 110 may be sufficiently rigid to be inserted into a conventional cigarette and at the same time, not be brittle to prevent its breaking when inserted into the conventional cigarette, a cigar or any other smoking article. - In certain embodiments, smoking
appliance 90 may comprise various herbs other than tobacco, or possibly any other medium that may be configured to mechanically acceptutensils 110 and be smoked therewith. For example, smokingappliance 90 may be configured as an artificial delivery device for plant extract(s) and/or therapeutic compounds, having a medium (e.g., a particulate or porous medium) that receives utensil(s) 110 mechanically, and may be activated by burning to release the plant extract(s) and/or therapeutic compounds from utensil(s) 110, to be inhaled by the user. In certain embodiments, the medium, and possibly utensil(s) 110, may be configured to burn and/or release the respective the plant extract(s) and/or therapeutic compounds at specified temperatures and under specified conditions that are different from typical tobacco burning conditions, e.g., to enhance the efficiency of delivery of the plant extract(s) and/or therapeutic compounds to the user. - In various embodiments,
utensils 110 may be between about 1-15 cm long, wherein the length may depend on the length ofsmoking appliance 90 into which it is to be inserted. For example,utensils 110 may be prepared at any length and then be trimmable (e.g., by the user, possibly at a blunt end or possibly at a sharp edge thereof) according to the length ofsmoking appliance 90 before or after insertion thereinto. In various embodiments,utensils 110 may be between about 0.5-3mm wide, such that is may be easily inserted into a conventional cigarette, avoiding harm or distortion ofsmoking appliance 90 and allowing regular use thereof. - According to some embodiments, at least one end of the stick-like device has a point, in order to enable the easy insertion thereof into the cigarette. For example, the stick-like device may be shaped similarly to a toothpick, which may or may not be blunt on one side, as long as it is sharp on the other side to ease insertion into the cigarette. For example, if the stick-like device is trimmed before insertion into the cigarette, it may be trimmed at an angle, so as to form a pointed end for insertion.
- In various embodiments,
utensils 110 may be made of any appropriate material that provide the required mechanical characteristics and allow incorporation of the plant extract. For example,utensils 110 may be made of wood, paper (e.g., hardened paper) or plastics such as polymers, e.g., polysaccharides, with cross-linked plant extract(s). The plant extract(s) may be associated toutensils 110 by various methods, such as immersion, soaking, coating, cross-linking, etc. - For example, in certain embodiments,
utensils 110 may be prepared by adding a cannabis oil into a polysaccharide solution; pouring the solution into a mold comprising at least one compartment, the compartment has the size and shape ofutensils 110; and chemically hardening or physically curing the solution in the compartment in order to obtainutensils 110. In various embodiments, the mold may comprise two or more compartments, with possibly different compartments differing from each other in shape, size or both.Utensils 110 may further be coated and/or inserted into respective sleeve elements, and aromatic materials, colors, hardening materials and/or curing material(s) may be added to the solution. Hardening methods may include chemical hardening by cross-linking and/or physical hardening by UV (ultraviolet) and/or heat radiation curing.Indications 120 may then be applied (e.g., attached or printed) uponutensils 110. - In certain embodiments,
utensils 110 may have inner spaces or compartments (with or without openings) into which the plant extract may be introduced, e.g., by immersion or injection. In certain embodiments,utensils 110 may be made of metal, e.g., having internal compartments or grooves configured to receive and hold the plant extract(s) and release the plant extract(s) upon heating ofmetal utensil 110 during smoking. In certain embodiments,metal utensils 110 may even be re-usable, e.g., by cleaning them after use and dipping them in plant extracts, as the spaces or grooves therein may be configured to hold a pre-defined amount of plant extract. In certain embodiments,utensils 110 may have a hollow channel through their whole length or through part of their length, e.g., like a borehole, which may receive and/or be filled by the plant extract. - In various embodiments,
utensils 110 may comprise the plant extract(s) or the user may introduce selected plant extract(s) intoutensil 110, e.g., withutensil 110 configured to receive a pre defined amount of plant extract. For example,utensil 110 may be provided with the plant extract(s) (e.g., cannabis oil, see below) and may be prepared by the user for smoking, e.g., by soaking or dippingutensil 110 in the plant extract and/or by filling hollow groove(s) or compartment(s) therein. Certain embodiments comprise kits for preparation ofutensil 110 by the user (either first-time or in a reusable version of utensil 110), with utensil(s) 110, plant extract(s) and respective instructions. - In certain embodiments, disclosed kits may comprise cannabis-
free utensils 110, cannabis oil, instructions for incorporating the cannabis oil into the cannabis-free utensils 110; and optionally means for incorporating the cannabis oil into the cannabis-free utensils 110 (e.g., an appropriately- shaped container, wetting means, etc.)· - In certain embodiments, disclosed kits may comprise different kinds of
utensils 110, containing different type of plant extract(s) and/or therapeutic compound(s). For example, users may select different types or compositions of plant extract(s) and/or therapeutic compound(s) at different times (e.g., during the day and at the evening), and therefore may use correspondingutensils 110 with different indicated compounds or combinations or amounts of compounds (e.g., having different amounts of THC and CBD). - According to some embodiments,
utensils 110 may be clad (covered or coated) by any appropriate sleeve-like element (not shown) configured to provide the desired physical properties, such as desired shape, strength, rigidity, and the like and/or configured to hold and then release pre defined amounts of plant extract(s). The sleeve or sleeve -like element may be removable or non removable fromutensil 110. - According to some embodiments,
utensils 110 may be made of soft material such as dough that is prepared to have specified shape, strength and resilience that are required for insertion thereof intosmoking appliance 90, and into which the plant extract may be incorporated. In certain embodiments,utensils 110 may be configured to be very thin, flexible or flakey - to be used in hand- rolled cigarettes or in pipes. The amount of usedutensil 110 may be related to the amount of released plant extract by diverse indications. - In various embodiments, the plant extract may comprise a cannabis extract and/or oil.
Indications 120 may comprise indication(s) 121 for a THC (tetrahydrocannabinol) content or level, and/or indications(s) 122 for predominant component(s) of the cannabis extract and/or oil, such as other cannabinoids, terpenes, or aromas (see non-limiting example inFigure 2 ). Other possible plant extract(s), usable inutensils 110 and/or as additions to the cannabis extract, comprise any plant extract or oil, various terpenes or any other plant extract or releasable compound. For example, any of menthol, pine oil, clove oil, eucalyptus oil, orange oil, lemon oil, or other essential oils, as well as flavor essences (e.g., lemon flavor, bubble gum flavor, enhanced cannabis flavors) may be included inutensil 110. - For example, in some embodiments,
utensils 110 may comprise condensed cannabis oil in a matrix configured to endow the product with the right rigidity, e.g., make it tooth -pick-like, so that it can be easily inserted to any existing cigarette, burns at the same rate as the cigarette, and leave no particles and minimum ash, while providing the cannabis oil or its products to the user.Utensils 110 may be provided at a range of different concentrations of CBD, THC, CBG (cannabigerol), and with different aromas (e.g., mint, lemon, orange) - which are indicated, e.g., by color code(s) on eachutensil 110 - Certain embodiments comprise packaged set(s) 130 including a plurality of
utensils 110 which may differ with respect to the at least one compound and thecorresponding indications 120, as exemplified schematically inFigure 3 . Complementary compositions of the plant extracts may be provided in each set (e.g., ones with little THC and much CBD and ones with much CBD and little THC). In certain embodiments,utensils 110 may be configured to allow insertion of more than oneutensil 110 at a time intosmoking appliance 90, e.g., utensils may be configured as thin spikes that can be inserted into cigars, or as rollable threads with color indications, and the user may select afew utensils 110 having a required combination of the plant extracts for each use (smoking) ofsmoking appliance 90. In certain embodiments, suchthin utensils 110 may comprise means for interconnectingmultiple utensils 110 to make their insertion intosmoking appliance 90, e.g., grooves or nooks may be used to attachutensils 110 to each other and enhance their longitudinal structural stability upon insertion. - For example, packaged set 130 of
utensils 110 may have cannabis extracts and/or oils having different levels of THC and/or different levels of other cannabinoids and/or of other components (e.g., terpenes) or characteristics (e.g., aromas) withcorresponding indications 120, as illustrated schematically inFigure 3 . - The contents of the cannabis oil incorporated into
utensils 110, and the ratios between the active ingredients found therein, may be determined according to any known protocols. Therefore, many types ofutensils 110 may be prepared, each having a specific, predefined content and ratio of active ingredients, in particular CBD (cannabidiol) and THC. The various types ofutensils 110 may be labeled according to their content, e.g., by size, color code, shape, labels and the like asindications 120. In a non-limiting example, the ratio between CBD and THC may be 10:1 ,utensils 110 may weigh about 100-150 mg and may correspondingly contain about 20-60mg of CBD, 2-6mg of THC, as well as additional supporting and hardening materials. According to some embodiments,utensils 110 may comprise any of about 20, 25, 30, 35, 40, 45, 50, 55 or 60 mg of CBD. According to some embodiments,utensils 110 may comprise any of about 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5 or 6.0mg THC. - In
case utensils 110 comprise polymer(s) to which the cannabis oil is cross-linked, the cross linking may be performed using various cross-linking methods and materials. For example, the cross-linking may be performed using microbial poly (gamma-glutamic acid) (PGA) with polysaccharides and the cannabis oil, which may be cross-liked as well or incorporated into the cross-linked product of the PGA and the polysaccharide. For example, the cross linking may be performed by using polylactic acid (PLA), including poly(L)lactide (PLLA) and poly(D)lactide (PLDA). For example, the cross linking may be performed using any appropriate cross-linkable composite, for example a composite prepared from polyethylene glycol) dimethyl ether (PEGDE)-500, LiCl04, fumed silica and about 10%wt methyl, butyl or octyl methacrylate. For example, the cross linking may be performed using any appropriate polysaccharide. For example, the cross linking may be performed by pre-chemically treating the cannabis oil using thiol-ene addition reactions, azide-alkyne cyclo addition reactions, Diels- Alder reactions and the like, wherein the formed adduct oil products are then cross-linked. The cannabis oil may also be pre-treated using triazolinediones (TADs), such as 4- phenyl-1,2,4-triazoline-3,5-dione and subsequently cross-linked. In any of the embodiments, the cross-linking mechanism may be selected to avoid releasing toxic fumes whenutensil 110 insmoking appliance 90 is smoked. In various embodiments, the material from which utensil 110 is prepared may be non-toxic and combustible, thereby providing a utensil that may burn together with the cigarette, while releasing carbonized plant extracts (e.g., cannabis oil), without having an intoxication effect on the user. The combustion rate of the stick-like device may be similar to that of a conventional cigarette. - In various embodiments,
utensils 110 may further comprise additives such as coloring and flavoring products, as well as enhancers, such as cocoa solids, licorice, tobacco extracts, and various sugars, and possibly perfume -like flavor(s)/fragrance(s) - any of which may be incorporated inutensils 110 as additional plant extracts and/or as additives. In various embodiments,utensils 110 may be coated by a material that contains aromatic elements, possibly one or more plant extracts. - Advantageously, disclosed
systems 100 andutensils 110 provide well-measured amounts of plant extracts that can be easily specified and controlled. Particularly in case of cannabis oils, disclosedsystems 100,utensils 110 andmethods 150 disclosed below - provide a reliable way of consuming cannabis oils and components thereof in a highly controllable and standardized methods.Indications 120 are further configured to clearly indicate the compounds to be smoked, and allow the user to select the required composition for any smoke. - Advantageously, disclosed
systems 100 andutensils 110 provide active materials at pre defined and known dosage, which is required e.g., in regulation procedures for medical use of cannabis and/or other plant extracts and/or any therapeutic compound. The amount of any of the active materials (e.g., cannabinoids) may be pre-defined and clearly indicated onutensil 110 and thus allow for regulated medical use thereof - through smoking which may be the preferred administration method for many patients and moreover has been proved to have high efficiency in this respect. For example, therapeutic compounds that target the brain, pass the blood brain barrier with higher efficiency when inhaled, and may be administered usingsystems 100 andutensils 110. In certain embodiments,utensil 110 and/or therapeutic compounds therewithin may be configured to further enhance the bioavailability of the latter by the heating and/or carbonization thereof during the administration process. - Advantageously, disclosed
systems 100 andutensils 110 may be used with the therapeutic compound(s) to provide new ways of administering dmgs that can be inhaled and are not damaged (or possibly modified favorably) by the smoking procedure. - Additional advantages include simple handling of utensils 110 (do not require rolling), simpler regulation compared to cannabis inflorescences due to the known and controlled amounts of THC or any other cannabinoid (e.g., CBD, CBN (Cannabinol), CBG, etc.) or any other compound (e.g., terpenes) in case of using cannabis extract or oil, consistent and repeatable smoking experience, and brand building possibilities due to the repeatability of the experience.
- Moreover,
utensils 110 may be used to deliver various plant extracts and possibly even therapeutic drugs or compounds that can be inhaled after heating and/or carbonizing during smoking. -
Figure 4 is a high-level flowchart illustrating amethod 150 of administering a plant extract or any compound at a controlled amount, according to some embodiments of the invention. The method stages may be carried out with respect tosystems 100 andutensils 110 described above, which may optionally be configured to implementmethod 150.Method 150 may comprise the following stages, irrespective of their order. -
Method 150 may comprise administering plant extract(s) at a controlled amount (stage 152) by applying the plant extract(s) to utensil(s) designed to be inserted into a smoking appliance (stage 155), indicating at least one compound that is included in the plant extract(s) on the utensil(s) (stage 160), and using the smoking appliance to inhale the plant extract(s) from the utensil(s) inserted therewithin (stage 170). - In certain embodiments,
method 150 may comprise administering at least one therapeutic compound at a controlled amount (stage 153) by applying the at least one therapeutic compound to utensil(s) designed to be inserted into a smoking appliance (stage 155) and using the smoking appliance to inhale the therapeutic compound(s) from the utensil(s) inserted therewithin (stage 170). - In certain embodiments ,
method 150 may further comprise designing the utensil(s) to be inserted into the smoking appliance (stage 157), e.g., by sticking or pushing the utensil into the smoking appliance. For example, the smoking appliance may be a cigarette and the utensil may be made as a stick that is thinner than the cigarette and has a sharp end configured to be inserted into tobacco of the cigarette throughout at least some, or possibly most, of a length of the cigarette (stage 158). Corresponding embodiments may be applicable to cigars or other smoking appliances such as pipes, hand-rolled cigarettes, bongs etc. - In certain embodiments,
method 150 may further comprise providing a plurality of utensils with different levels of the indicated at least one compound and/or with different combinations of the therapeutic compound(s) (stage 180). - For example, the plant extract(s) may comprise cannabis extract(s) and/or oil(s), and/or essential plant oils.
Method 150 may further comprise indicating a THC level, predominant components (e.g., cannabinoids, terpenes) and/or characteristics (e.g., aromas) of the cannabis extract and/or oil (stage 182).Method 150 may further comprise providing a plurality of utensils with different levels of THC and/or with different predominant components and/or characteristics (stage 185). -
Figures 5 and 6 are schematic illustrations ofsystems 200 havingbeehives 80 configured to provide complexes of honey and plant extracts and/or therapeutic compound(s), according to some embodiments of the invention.Systems 200 may comprisebeehives 80 having substrate(s) 210 infused with plant extract(s) and/or therapeutic compound(s) - that are attachable onto at least onehive region 85 that is stepped on by bees, wherein substrate(s) 210 are configured to soil bees that step thereon with the plant extract and/or the therapeutic compound(s). For example, substrate(s) 210 such as pads (made e.g., of sponge or foam) soaked by the plant extract(s) and/or the therapeutic compound(s), may be attached to entrance(s) to hive 80 and may have any corresponding shape (see, e.g., inFigures 5 and 6 , the openings andcorresponding substrates 210 may be straight or round, narrow or broad, etc.). - Advantageously, bees stepping on
substrate 210 and being soiled by the plant extract(s) and/or the therapeutic compound(s) may then mix the plant extracts, intentionally or unintentionally, in the produced honey to yield a complex of honey and the plant extracts and/or therapeutic compound(s), which is not achievable by other means (such as mixing prepared honey with plant extracts and/or therapeutic compounds). - For example, the plant extracts may comprise cannabis extract and/or oil, to yield a complex of honey and cannabis that is not achievable by other means, as the complexes may include bonds between the honey and the plant extracts that are formed during the honey processing by the bees. The cannabis in the cannabis-honey complex may be incorporated into the honey during the honey's preparation process by the bees from pollen. According to some embodiments, the cannabis-honey complex may have a unique HPLC (High Pressure/Performance Liquid Chromatography) pattern, different from other types of honey and/or other types of cannabis. According to some embodiments, the HPLC fingerprint of the cannabis-honey complex is unique in comparison to other types of honey and/or other types of cannabis.
- In certain embodiments,
beehive 80 may be designed to cause at least one part of the body of thebees entering beehive 80 to touch at least part ofsubstrate 210 atentrance 85. For example,regions 85 may be configured to causebees contact substrate 210 with cannabis oil with their bodies, e.g., legs, abdomen and/or thorax, while enteringbeehive 80. The thus soiled bees may be at least partly coated or stained with cannabis oil, which they may then take with them intobeehive 80 and possibly mix with honey to yield the cannabis-honey complex during the honey-preparation process. According to some embodiments,beehive 80 may be designed to induce contact of entering bees withsubstrate 210. For example, the diameter or width of theentrance 85 to beehive 80 may be restricted, so that at least on one of its dimensions is between about 0.3-1.0cm and thereby induce contact between the bee andsubstrate 210. - In certain embodiments, in addition or alternatively to using
substrate 210, smoke of carbonized cannabis oil may be distributed onto and/or in the surroundings ofbeehive 80, exposing the bees and/orbeehive 80 to carbonized cannabis, which may then be incorporated into the honey to yield the cannabis-honey complex. - In certain embodiments, in addition or alternatively to using
substrate 210, cannabis oil may be sprayed onto the internal elements ofbeehive 80, enhancing the incorporation of the cannabis oil by the bees into the cannabis-honey complex. - Advantageously, disclosed cannabis-honey complexes and/or complexes of honey and therapeutic compound(s) - may have enhanced therapeutic effects, with respect to either honey alone, cannabis alone, and therapeutic compound(s) alone, or mechanical mixtures thereof. The preparation process of the cannabis-honey complex by the bees may induce additional beneficial properties to the disclosed products. Examples for such properties include therapeutic and/or recreational effects. Moreover, as administration method, cannabis-honey complexes may be more effective and/or more becoming than other methods of cannabis administration.
- Certain embodiments comprise processes of preparing new complexes of honey and therapeutic compound(s) through the disclosed methods and systems of soiling bees with the therapeutic compound(s) and letting the bees integrate the therapeutic compound(s) into the honey.
-
Figure 7 is a high-level flowchart illustrating amethod 250, not covered by the claimed subject-matter, of deriving a complex of honey and plant extract(s) and/or therapeutic compound(s), according to some embodiments of the invention. The method stages may be carried out with respect tosystems 200 described above, which may optionally be configured to implementmethod 250.Method 250 may comprise the following stages, irrespective of their order. -
Method 250 comprises deriving a complex of honey and one or more plant extract and/or therapeutic compound(s) (stage 255) by applying the plant extract and/or therapeutic compound(s) onto a substrate (stage 260) and attaching the substrate onto at least one hive region that is stepped on by bees (stage 265). Applying 260 and the substrate are configured to soil bees that step on the substrate with the plant extract and/or therapeutic compound(s) (stage 270),method 250 further comprises collecting the complex from the hive (stage 280).Method 250 may further comprise configuring the substrate as one or more pads attached to at least one entrance to the hive (stage 267). The pads may be shaped according to the corresponding shape of the openings in the hives, e.g., straight or round, narrow or broad, etc. - For example, the plant extract may comprise cannabis extract and/or oil, and disclosed
method 250 may provide an efficient way of complexing cannabis extract and/or components thereof with honey. - In some embodiments,
systems 200 and/ormethods 250 may be configured to produce complexes of honey and therapeutic compound(s) that may be used as new therapeutic compounds having new therapeutic effects. - It is noted that a value modified by the term "about" is understood to encompass ±10% of the value.
- In the above description, an embodiment is an example or implementation of the invention. The various appearances of "one embodiment", "an embodiment", "certain embodiments" or "some embodiments" do not necessarily all refer to the same embodiments. Although various features of the invention may be described in the context of a single embodiment, the features may also be provided separately or in any suitable combination. Conversely, although the invention may be described herein in the context of separate embodiments for clarity, the invention may also be implemented in a single embodiment. Certain embodiments of the invention may include features from different embodiments disclosed above, and certain embodiments may incorporate elements from other embodiments disclosed above. The disclosure of elements of the invention in the context of a specific embodiment is not to be taken as limiting their use in the specific embodiment alone. Furthermore, it is to be understood that the invention can be carried out or practiced in various ways and that the invention can be implemented in certain embodiments other than the ones outlined in the description above.
- The invention is not limited to those diagrams or to the corresponding descriptions. For example, flow need not move through each illustrated box or state, or in exactly the same order as illustrated and described. Meanings of technical and scientific terms used herein are to be commonly understood as by one of ordinary skill in the art to which the invention belongs, unless otherwise defined. While the invention has been described with respect to a limited number of embodiments, these should not be construed as limitations on the scope of the invention, but rather as exemplifications of some of the preferred embodiments. Other possible variations, modifications, and applications are also within the scope of the invention. Accordingly, the scope of the invention should not be limited by what has thus far been described, but by the appended claims and their legal equivalents.
Claims (13)
- A method of producing a utensil for administering carbonized cannabinoids at a standardized and controlled amount, the method comprising:applying a cannabis extract or oil to the utensil, andapplying, to the utensil, an indication identifying amounts of cannabinoids, terpenes and terpenoids that is included in the cannabis extract or oil,wherein:
said utensil is designed to be inserted into a smoking appliance to enable inhalation of a specified ratio and amounts of said cannabinoids, terpenes and terpenoids from the utensil inserted therewithin. - The method of claim 1, further comprising a step of designing the utensil into a shape enabling is insertion into the smoking appliance by sticking.
- The method of claim 1, wherein the smoking appliance is a cigarette and the utensil is a stick that is thinner than the cigarette and has a sharp end configured to be inserted into tobacco of the cigarette throughout at least some of a length of the cigarette.
- The method of claim 1, wherein different utensils are produced with different levels of the indicated amounts of cannabinoids, terpenes, and terpenoids.
- The method of claim 1, wherein the indication of cannabinoids includes indication of THC (tetrahydrocannabinol) level.
- The method of claim 5, wherein different utensils are produced with different levels of THC and utensils with different terpenes or terpenoids.
- A utensil comprising:a cannabis extract or oil comprising cannabinoids, terpenes and terpenoids, andan indication identifying amounts of said cannabinoids, terpenes and terpenoids,wherein the utensil is designed to be inserted into a smoking appliance and release the cannabis extract or oil upon smoking the smoking appliance.
- The utensil of claim 7, wherein the smoking appliance is a cigarette and the utensil is a stick that is thinner than the cigarette and has a sharp end configured to be inserted into tobacco of the cigarette throughout at least some of a length of the cigarette.
- The utensil of claim 7, wherein the indication further comprises an indication for a THC level.
- The utensil of claim 7, wherein the utensil is made of porous material.
- A packaged set of a plurality of the utensils of claims 7, wherein the utensils in the set differ with respect to the at least one compound and the corresponding indication.
- The packaged set of the utensils of claim 11, wherein the plant extract is a cannabis extract or oil, wherein the indications comprises at least one indication of a level of at least one cannabinoid and wherein the utensils have corresponding different levels of the at least one cannabinoid.
- The packaged set of the utensils of claim 12, wherein the indications comprise an indication for a THC level and an indication for at least one component of the cannabis extract or oil, and wherein the utensils have different levels of THC or have different components, or levels thereof.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862703657P | 2018-07-26 | 2018-07-26 | |
| US201862723001P | 2018-08-27 | 2018-08-27 | |
| PCT/IL2019/050846 WO2020021553A1 (en) | 2018-07-26 | 2019-07-25 | Plant extracts and therapeutic compounds in smoking utensils and in honey complexes |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| EP3826481A1 EP3826481A1 (en) | 2021-06-02 |
| EP3826481A4 EP3826481A4 (en) | 2022-04-20 |
| EP3826481C0 EP3826481C0 (en) | 2023-10-18 |
| EP3826481B1 true EP3826481B1 (en) | 2023-10-18 |
Family
ID=69180296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19841126.6A Active EP3826481B1 (en) | 2018-07-26 | 2019-07-25 | Plant extracts and therapeutic compounds in smoking utensils and in honey complexes |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11582996B2 (en) |
| EP (1) | EP3826481B1 (en) |
| BR (1) | BR112021001456A2 (en) |
| CA (1) | CA3107730C (en) |
| ES (1) | ES2970130T3 (en) |
| IL (2) | IL304013B2 (en) |
| WO (1) | WO2020021553A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL304013B2 (en) * | 2018-07-26 | 2024-05-01 | Stickit Ltd | Plant extracts and therapeutic compounds insmoking utensils and in honey complexes |
| US20210378310A1 (en) * | 2019-02-22 | 2021-12-09 | Nerudia Limited | Smoking Substitute Consumable |
| WO2023184618A1 (en) * | 2022-03-31 | 2023-10-05 | 昆明百泓健康产业有限公司 | Cigarette insertion strip and preparation method therefor |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2072361A (en) | 1935-04-25 | 1937-03-02 | Ehrig | Device for flavoring cigarettes |
| DE1873551U (en) * | 1963-02-08 | 1963-06-06 | Ernst Ruediger | CIGARETTE POT. |
| US6730330B2 (en) * | 2001-02-14 | 2004-05-04 | Gw Pharma Limited | Pharmaceutical formulations |
| DE202004009457U1 (en) * | 2004-09-09 | 2004-11-25 | Nentwig, Walter | Aromatic stick of any shape or size imparts an individual aroma to tobacco e.g. mini-cigars |
| US8282739B2 (en) * | 2006-08-03 | 2012-10-09 | Philip Morris Usa Inc. | Preformed cigarette having a specifically defined immobilized flavorant additive insert positioned therein |
| JP2017169447A (en) * | 2014-08-05 | 2017-09-28 | 日本たばこ産業株式会社 | Flavor imparting agent for smoking article |
| US20160037823A1 (en) * | 2014-08-11 | 2016-02-11 | Aari Ruben | Medical therapy using cigarettes |
| US9220298B1 (en) * | 2014-09-13 | 2015-12-29 | Viiital, LLC | Technologies for smoking |
| CN204362945U (en) * | 2014-12-22 | 2015-06-03 | 广西中烟工业有限责任公司 | A kind of Three-element composite filter core containing fiery numb seed extract porous particle |
| US20170172200A1 (en) * | 2015-12-16 | 2017-06-22 | R.J. Reynolds Tobacco Company | Flavor additive accessory |
| US20170273349A1 (en) * | 2016-03-28 | 2017-09-28 | David Harold Moore | Cannabis-Hemp Smoking Blend |
| US20170347701A1 (en) * | 2016-06-01 | 2017-12-07 | Christopher Pitta | Method for administering tetra-hydrocannabinol in tobacco |
| WO2018205038A1 (en) * | 2017-05-12 | 2018-11-15 | Tetra Bio-Pharma Inc. | Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling |
| US10383358B2 (en) * | 2017-06-14 | 2019-08-20 | Digital Rarity Llc | Cannabinoid containing cannabis extract infused into rolling paper |
| US10548347B2 (en) * | 2018-02-23 | 2020-02-04 | American Snuff Company, Llc | Container for smokeless tobacco products |
| IL304013B2 (en) * | 2018-07-26 | 2024-05-01 | Stickit Ltd | Plant extracts and therapeutic compounds insmoking utensils and in honey complexes |
-
2019
- 2019-07-25 IL IL304013A patent/IL304013B2/en unknown
- 2019-07-25 ES ES19841126T patent/ES2970130T3/en active Active
- 2019-07-25 EP EP19841126.6A patent/EP3826481B1/en active Active
- 2019-07-25 CA CA3107730A patent/CA3107730C/en active Active
- 2019-07-25 IL IL280409A patent/IL280409B2/en unknown
- 2019-07-25 WO PCT/IL2019/050846 patent/WO2020021553A1/en not_active Ceased
- 2019-07-25 BR BR112021001456-0A patent/BR112021001456A2/en not_active Application Discontinuation
-
2021
- 2021-01-26 US US17/158,360 patent/US11582996B2/en active Active
-
2023
- 2023-02-19 US US18/111,585 patent/US20230189875A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210145043A1 (en) | 2021-05-20 |
| WO2020021553A1 (en) | 2020-01-30 |
| IL280409A (en) | 2021-03-25 |
| IL304013A (en) | 2023-08-01 |
| IL280409B2 (en) | 2023-11-01 |
| IL304013B2 (en) | 2024-05-01 |
| EP3826481A1 (en) | 2021-06-02 |
| BR112021001456A2 (en) | 2021-04-27 |
| US11582996B2 (en) | 2023-02-21 |
| US20230189875A1 (en) | 2023-06-22 |
| IL280409B1 (en) | 2023-07-01 |
| ES2970130T3 (en) | 2024-05-27 |
| EP3826481A4 (en) | 2022-04-20 |
| IL304013B1 (en) | 2024-01-01 |
| CA3107730A1 (en) | 2020-01-30 |
| EP3826481C0 (en) | 2023-10-18 |
| CA3107730C (en) | 2023-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230189875A1 (en) | Plant extracts and therapeutic compounds in smoking utensils and in honey complexes | |
| JP6932859B2 (en) | How to prepare a low inhalation resistance polylactic acid long fiber bundle filter rod to reduce the temperature of tobacco smoke | |
| DE69012823T2 (en) | TOOLS TO ADJUST SMOKING OR USE IN NON-SMOKING AREAS. | |
| EP2136659B1 (en) | Smokeless cigarette and method for the production thereof | |
| ES2986377T3 (en) | Product | |
| DE102007033083A1 (en) | Tobacco substitute and tobacco substitute molding | |
| KR20210018948A (en) | Delayed Release Flavoring and Its Application in Chinese Flavored Tobacco Products | |
| WO2012062029A1 (en) | Herbal functional cigarette with natural aroma for nourishing lung, relieving cough and asthma, and eliminating phlegm | |
| CN106070368A (en) | A kind of natural green mosquito incense | |
| KR20010030937A (en) | A cigarette of ginkgo leaves | |
| EP4544927A1 (en) | Filter for smoking article containing lyocell tow, manufacturing method, and smoking article comprising same | |
| US10918596B2 (en) | Oral delivery system and method | |
| CN106509978A (en) | Thuja sutchuenensis Franch formula for cigarettes | |
| JP7272554B2 (en) | Filters for smoking articles containing solid flavorants and methods of making same | |
| KR20130095598A (en) | Aromatic stuffed-filter, the method of producing the same, and the tobacco pipe including thereof | |
| CN101181607A (en) | Fragrant cream for giving up smoke | |
| NL2014099B1 (en) | Cigarette filter. | |
| CN1139343C (en) | Smoking giving up tea cigarette | |
| JP3248528U (en) | Incense | |
| WO2013037517A2 (en) | Use of a heat-resistant fibre material as support material in waterpipes and inhalers | |
| Pickworth et al. | Smokable drugs: pharmacologic basis for consumer appeal | |
| JP2006282624A (en) | Incense or incense to improve nasal obstruction | |
| CN1622767A (en) | Filter for cigarette, and cigarette | |
| JP2025534746A (en) | Aerosol-generating beads, methods for preparing the beads, and compositions and articles comprising the beads | |
| JP2025507752A (en) | Smoking products and methods of manufacture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20210208 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20220318 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A24D 1/00 20200101ALI20220314BHEP Ipc: A24F 25/00 20060101ALI20220314BHEP Ipc: A24B 15/28 20060101AFI20220314BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20221214 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20230509 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602019039776 Country of ref document: DE |
|
| U01 | Request for unitary effect filed |
Effective date: 20231117 |
|
| U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20231123 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240119 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240218 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240218 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240119 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2970130 Country of ref document: ES Kind code of ref document: T3 Effective date: 20240527 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240118 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602019039776 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| U20 | Renewal fee for the european patent with unitary effect paid |
Year of fee payment: 6 Effective date: 20240724 |
|
| 26N | No opposition filed |
Effective date: 20240719 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240730 Year of fee payment: 6 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20240809 Year of fee payment: 6 Ref country code: ES Payment date: 20240829 Year of fee payment: 6 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231018 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240725 |